Health News Releases

September 12, 16:20

Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation

Medicines Discovery Catapult (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmd.catapult.org.uk%2F&esheet=54321838&newsitemid=20250911458780&lan=en-US&anchor=Medicines+Discovery+Cat

September 12, 15:20

Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

Ferring Pharmaceuticals Co., Ltd. announced that the PMDA has accepted the NDA for nadofaragene firadenovec for review, following submission on August 27th, 2025. This non-replicating gene therapy, ad

September 12, 13:35

Nominations Open for Fifth Edition of Aster Guardians Global Nursing Award 2026 Worth USD 250,000

Aster DM Healthcare has announced the launch of the fifth edition of the Aster Guardians Global Nursing Award, one of the world’s most prominent recognition for nursing excellence worth USD 250,000.

September 12, 10:55

Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase

Promega Corporation (https://www.promega.kr/?utm_source=businesswire.com&utm_medium=referral&utm_campaign=%28referral%29) has entered a strategic partnership with Watchmaker Genomics (https://www.watc

September 11, 15:50

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking pla

September 10, 16:30

Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market

Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare mar

September 10, 16:00

France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory m

September 08, 17:39

Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54319980&newsitemid=20250908503054&lan=en-US&ancho

September 07, 16:11

U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Rec

September 07, 16:00

Amazfit Ambassador Ruth Croft Claims Victory at the 2025 UTMB

Amazfit (https://us.amazfit.com/), a leading global smart wearable brand by Zepp Health (NYSE: ZEPP), is proud to celebrate Ruth Croft’s achievement at the 2025 UTMB, earning first place and completin

September 07, 15:50

Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages

Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimiz

September 07, 12:20

Rigaku Joins Two Partners in Establishing RIGAKU/JEOL-iCeMS Innovation Core and Concluding a Cooperation Agreement

On September 4, 2025, Rigaku Corporation, a global solution partner in X-ray analytical systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President & CEO: Jun

September 05, 17:15

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

Biocytogen Pharmaceuticals (https://biocytogen.com/) (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drug

September 05, 14:30

From AI-powered EHRs to Real-Time Data Sharing, InterSystems Asia Healthcare Summit 2025 Spotlights Indonesia as a Digital Health Beacon in Southeast Asia

InterSystems, a creative data technology provider managing more than one billion health records globally, recently held their Asia Healthcare Summit 2025, bringing together more than 200 regional and

September 05, 12:00

IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications

IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com&esheet=54317958&newsitemid=20250904544995&lan=en-US&anchor=IFF&index=1&md5=6f4e9fc0d09b0ce3e1b691904d2aa7c2) (NYSE: I

September 04, 14:38

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 millio

September 03, 16:40

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

Polpharma Biologics S.A. (“Polpharma Biologics”), specialized in the development and manufacturing of biosimilars, today announced that it has signed licensing agreements with MS Pharma, a leading bio

September 03, 09:53

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector. Wei

September 03, 09:47

IFF Tackles Top Challenges in Baking at IBIE 2025

IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.iff.com&esheet=54316321&newsitemid=20250902465856&lan=en-US&anchor=IFF&index=1&md5=e0f385d40a254be09c3e473ae8058dde) (NYSE: IF

August 31, 14:35

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) o

August 29, 11:30

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a signifi

August 28, 11:20

IFF and Reservas Votorantim Sign Bioprospecting Partnership in Brazil

IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com%2F&esheet=54313323&newsitemid=20250827881934&lan=en-US&anchor=IFF&index=1&md5=aa3a4d050325a3165d01099ca70062f3) (NYSE

August 26, 13:40

SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announ

August 26, 10:50

BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54312218&newsitemid=20250825210828&lan=en-US&anchor=BeOne+Medicines+Ltd&index=1&md5

August 22, 09:35

European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54311084&newsitemid=20250821182068&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

August 13, 10:10

PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis

Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54306533&newsitemid=20250812652131&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=43390a81b573

August 08, 17:10

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialization of PB016, a proposed biosi

August 08, 15:00

BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates

BeOne Medicines Ltd. (https://beonemedicines.com/) (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the second quarter o

August 08, 11:20

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.histosonics.com&esheet=54304409&newsitemid=20250807749442&lan=en-US&anchor=HistoSonics&index=1&md5=f0e9f5c34e97c8b8bfd

August 05, 15:50

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Concept Medical Inc. (https://www.conceptmedical.com/), a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Ba

August 05, 15:00

Nucleus Network Acquires Hammersmith Medicines Research

Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom’s most respected early phase clini

August 01, 13:40

BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54299902&newsitemid=20250731014937&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

July 30, 16:11

Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54297300&newsitemid=20250727920112&lan=en-US&anc

July 30, 15:40

Rigaku Launches XTRAIA XD-3300 Mass Production for Semiconductor Market

Rigaku Corporation, a global solution partner in X-ray metrology systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), ha

July 30, 15:20

Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to announce that we have received the highly regarded Veeva Hero award presented at the 2025 Veeva R&D and Q

July 29, 11:54

BARRICURE Officially Sponsors SPDU 2025 in Malaysia Collaborating with CHAYA AND LIGHT SDN. BHD. for Local Professional Promotion

BARRICURE, the dermatology-focused medical device brand of MEDIPEAU Inc, Ltd., participated as an official sponsor at the Sarawak Paediatric Dermatology Update 2025 (SPDU 2025), held on July 26, 2025,

July 29, 11:10

BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54297275&newsitemid=20250728331235&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

July 29, 10:55

Biocytogen Upgrades Preclinical Service Platform and Launches Revamped Global Website

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo

July 27, 10:33

Endoscopic AI: AI Medical Service Inc. Has Obtained Regulatory Approval from Thailand’s FDA for Its Gastric AI-based Endoscopic Diagnosis Support System

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce that it has received medical device approval from the

July 25, 13:30

Amazfit Announces Ultra Runner Rod Farvard as New Brand Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced ultra runner Rod Farvard as the newest athlete ambassador. Farvard’s approach to endurance racing, a combin

July 25, 11:30

LEO Pharma Announces FDA Approval of ANZUPGO® (delgocitinib) Cream in the U.S.

LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream (20 mg/g) for the topical treatment of m

July 24, 14:52

Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2025. · Record net sales of 2.448 billion USD, representing net

July 23, 14:30

Takeda Receives FDA 510(k) Clearance for HyHub™ and HyHub™ Duo Devices to Simplify HYQVIA® Administration

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHub™ and HyHub™ Duo, devices

July 22, 14:05

SS&C Technologies to Acquire Calastone

SS&C Technologies Holdings, Inc. (https://www.ssctech.com/?utm_campaign=SSC2025-Enterprise-Press-Release-0725&utm_medium=pressrelease&utm_source=prnews&utm_content=SSNC-to-acquire-Calastone) (Nasdaq:

July 22, 14:00

Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula

Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial eval

July 20, 14:00

NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced Baltimore Ravens running back Derrick Henry as the newest elite athlete to join its growing roster of ambas

July 18, 11:30

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Economics

With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offer

July 17, 14:23

Galderma Unveils Final Nine-Month Data Showing Lasting Efficacy and Patient Satisfaction With Its Injectable Aesthetics Portfolio When Addressing Facial Aesthetic Changes After Medication-Driven Weight Loss

Galderma has revealed positive final data from a phase IV first-of-its-kind trial exploring the benefits of Restylane Lyft or Contour in combination with Sculptra to address the aesthetic concerns of

July 17, 10:51

PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala

PCI Pharma Services (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fpci.com%2F&esheet=54289682&newsitemid=20250714606219&lan=en-US&anchor=PCI+Pharma+Services&index=1&md5=d5060a2fa63

July 16, 15:00

Statens Serum Institut Large Danish Study Finds No Link Between Vaccines and Autism or 49 Other Health Conditions

A new Danish study finds no association between aluminum in childhood vaccines and 50 different health conditions, including autism, asthma, and autoimmune diseases. The findings reaffirm the safety o

July 16, 09:55

SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announ

July 15, 14:50

HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 7 Million Blue Cross Blue Shield Highmark Members

HistoSonics (https://histosonics.com/), the manufacturer of the Edison® Histotripsy System, today announced that Highmark Blue Cross Blue Shield has issued four new positive medical policy decisions f

July 14, 16:29

Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54289672&newsitemid=20250714054710&lan=en-US&ancho

July 13, 09:55

iFIT Partners with Samsung Health to Bring Personalized Fitness and Wellness to Millions Across the Globe

iFIT, a global leader in connected fitness and interactive content, today announced a groundbreaking partnership with Samsung Health, one of the world’s most recognized names in technology. This strat

July 11, 17:15

Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research

Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3

July 11, 10:50

Newly Elected Directors of Sinovac Hold the First Board Meeting

Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprisin

July 11, 10:20

Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo

July 10, 14:40

Rigaku Announces STAvesta, a Thermal Analyzer Tailor-made for Next-generation Material Development

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has launched worldwide sales of STAvesta, a thermal analyzer

July 09, 11:35

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts - early

July 09, 10:45

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company see

July 08, 15:10

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

CorFlow Therapeutics AG (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.corflow.com&esheet=54285516&newsitemid=20250707156114&lan=en-US&anchor=CorFlow+Therapeutics+AG&index=1&md5

July 04, 10:00

Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year

In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost

July 02, 17:08

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ovarian stimulation in vitro

July 01, 14:13

Galderma Announces Departure of Its Chief Financial Officer

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive o

July 01, 14:10

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (hu

June 29, 14:10

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD001

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction ass

June 27, 14:20

Groups Representing Patients, Healthcare Professionals and Pharmaceutical Industry Author New Principle on Use of AI In Healthcare

Six leading international organizations representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry have today adopted the first joint ethical principle in the h

June 27, 13:45

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

In a significant showcase for investors, BeOne Medicines Ltd. (https://beonemedicines.com/) (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will announce major advancements to its

June 27, 11:20

IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation

IFF (https://www.iff.com/) (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—has released its 2024 Do More Good Report (https://www.iff.com/sustainabilityre

June 27, 10:20

MEDIPEAU Inc Showcases “BARRICURE” Medical Device Brand for Damaged Skin at Malaysia’s ‘Immunodermatology Updates 2025’ Symposium

On June 23, 2025, the ‘Immunodermatology Updates 2025’ symposium was held in Malaysia. At this event, CHAYA AND LIGHT SDN. BHD., the official Malaysian distribution partner of MEDIPEAU Inc., introduce

June 26, 11:00

Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer’s and Parkinson’s Single Cell Datasets

Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on understandin

June 25, 16:20

Takeda Announces New Assignments of Directors

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today. Taked

June 25, 15:00

Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients li

June 24, 16:20

Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries

H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired

June 24, 13:30

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper exa

News by Region

News by Industry

The largest press release distribution network in Korea

Global PR service

News by region

News by industry